Investment Strategy

Investing in pioneeringbiotech ventures

We invest in biotech ventures developing novel drugs, across a diversity of modalities and therapeutic areas.

We drive value inflection points throughout preclinical and clinical development

Products and platforms

We invest in both asset-centric companies and product-enabling platform technologies with a proprietary pipeline. We are agnostic to the therapeutic modality and our investments feature small molecules, antibodies, viruses and living cells.

Development stage

We seek drug candidates built on strong scientific foundations, backed by preclinical models or initial clinical data.

We support companies through each stage of development, with a core focus on late preclinical and early clinical projects. We provide companies with the means to generate clinical efficacy in patients.

Taking an active role

We are biotech entrepreneurs, with broad experience in building new scientific ventures.

We are supportive and hands-on investors.

We invest in international syndicates with other dedicated life sciences and healthcare investors that share our vision and commitment to supporting companies that will make a major impact in their fields.

Anticipating the
next wave of medical

We are deeply rooted within the pharma industry and supported by a first-class network of contacts and advisors.

Equipped with first-hand market insight, we anticipate emerging therapeutic trends and growing areas of interest across a diversity of indications.